BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Since miR-29b is downregulated in CML patients, it was selected for further investigation showing that overexpression of miR-29b in the K562 CML cell line leads to a decrease of BCR::ABL1 expression.